Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia 8Lymphoma, Follicular 6Leukemia, Myeloid, Acute 6Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Burkitt Lymphoma 5Lymphoma, Non-Hodgkin 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Blast Crisis 4Waldenstrom Macroglobulinemia 3Leukemia, Lymphocytic, Chronic, B-Cell 3Graft vs Host Disease 3Dendritic Cell Sarcoma, Interdigitating 3Sezary Syndrome 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Multiple Myeloma 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Extranodal NK-T-Cell 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2

Interventions

Gemcitabine 74Paclitaxel 60Capecitabine 60Fluorouracil 58Oxaliplatin 57Docetaxel 51Bevacizumab 51Leucovorin 48Nivolumab 41Irinotecan 40Cisplatin 40Carboplatin 37Cetuximab 34Radiosurgery 33pembrolizumab 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Albumin-Bound Paclitaxel 21Pemetrexed 20Doxorubicin 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × Methylprednisolone Hemisuccinate × Clear all
NCT02887976 2020-07-22

Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201

GU Research Network, LLC

Phase 3 Completed
2 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡